C

Clene
D

CLNN

4.09000
USD
-0.11
(-2.62%)
Market Closed
Volume
8,298
EPS
-5
Div Yield
-
P/E
-1
Market Cap
32,637,079
News

Title: Clene Inc.

Sector: Consumer Defensive
Industry: Packaged Foods
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercializationof dietary supplements (Supplements).